col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: Henry Stewart Talks

100 Results       Page 1

 [1] 
  original article Journal Date Title Authors All Authors
1 [GO] The Biomedical & Life Sciences Collection 2024―Aug―29 The Global Virus Network: collaboration to address pandemic and regional threats Sten H. Vermund
2 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 COVID-19 epidemiology and variants: new challenges and future of the pandemic Ralph Baric
3 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 COVID-19 epidemiology and potential treatments: follow up interview Ralph Baric
4 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 FTIR spectroscopy for COVID-19 detection in saliva Andrei A. Bunaciu
5 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 The COVID-19 coronavirus outbreak: October 2020 update Jonathan Temte
6 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 The COVID-19 coronavirus outbreak: May 2020 update Jonathan Temte
7 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 The COVID-19 coronavirus outbreak: a current view Jonathan Temte
8 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 The COVID-19 coronavirus outbreak: March 2020 update Jonathan Temte
9 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Remdesivir COVID-19 clinical trial Mahesh Parmar
10 [GO] The Business & Management Collection 2024―Jul―25 COVID-19 and the Federal Reserve Lewis Jackson
11 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Comparison of COVID-19 and seasonal HCoV pathologies and transfer to endemic state Rustom Antia
12 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Risk of re-emergence of COVID-19 after exit from lockdown Leonardo Lopez
13 [GO] The Business & Management Collection 2024―Jul―25 Insolvencies in the era of COVID-19 Keith Pond
14 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 The anti-viral immune response to COVID-19 Danny Altmann
15 [GO] The Business & Management Collection 2024―Jul―25 International aid for developing countries in the age of Covid-19 Anne Krueger
16 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Convalescent plasma therapy as a treatment for COVID-19 Manu Shankar-Hari
17 [GO] The Business & Management Collection 2024―Jul―25 Globalisation and the impact of COVID-19 Ian Goldin
18 [GO] The Business & Management Collection 2024―Jul―25 Business continuity: using remote work during COVID-19 Rowena Hennigan
19 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Understanding statistics in epidemics and pandemics: lessons learned from COVID-19 Sarah Ransdell
20 [GO] The Business & Management Collection 2024―Jul―25 Zomato: repositioning amid COVID-19 K. G. Suresh
21 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Tuberculosis and COVID-19 Giovanni Battista Migliori
22 [GO] The Business & Management Collection 2024―Jul―25 Online learning in education during COVID-19 Rowena Hennigan
23 [GO] The Business & Management Collection 2024―Jul―25 Government response and economic impact during COVID-19 James K. Galbraith
24 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Human movement patterns and local spread of COVID-19 Ben Cowling
25 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Triage and end of life care planning in COVID-19 Robin Taylor
26 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Update on the SNG001 drug, an INFβ therapy for COVID-19 Stephen Holgate
27 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Complement activation in COVID-19 Jeffrey Laurence
28 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Human challenge trials for vaccines against COVID-19 Peter Smith
29 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Interferon-α2b as a therapy for COVID-19 Eleanor N. Fish
30 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Rheumatic diseases and COVID-19 Zachary Wallace
31 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 The neurological symptoms of COVID-19 Michael Zandi
32 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Medical wearable devices for tracking symptoms of COVID-19 John Rogers
33 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Development of PRO-140 (Leronlimab) as a treatment for COVID-19 Jacob Lalezari
34 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 The impact of COVID-19 in the elderly and in care homes David Strain
35 [GO] The Business & Management Collection 2024―Jul―25 The impact of Covid-19 on cybersecurity and data privacy Claudiu Popa
36 [GO] The Business & Management Collection 2024―Jul―25 The impact of COVID-19 on higher education Wendy M. Purcell
37 [GO] The Business & Management Collection 2024―Jul―25 The impact of COVID-19 on international trade Mona Chung
38 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Impact of COVID-19 on neuropsychiatric disorders and mental health Anthony David
39 [GO] The Business & Management Collection 2024―Jul―25 The effect of COVID-19 on online grocery sales: Taylor Farms Heather Sprandel
40 [GO] The Business & Management Collection 2024―Jul―25 The impact of Covid-19 on organizations Paul J. H. Schoemaker
41 [GO] The Business & Management Collection 2024―Jul―25 The impact of Covid-19 on psychological safety in the workplace Amy C. Edmondson
42 [GO] The Business & Management Collection 2024―Jul―25 The impact of Covid-19 on tourism Robin Barker
43 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 The COVID-19 outbreak: an update on the SARS-CoV-2 virus Ralph Baric
44 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 The COVID-19 outbreak: April 2021 update Jonathan Temte
45 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Predicting COVID-19 outbreaks by measuring SARS-CoV-2 RNA in sewage sludge Jordan Peccia
46 [GO] The Business & Management Collection 2024―Jul―25 How organizations respond to crisis: five case studies from the COVID-19 pandemic Heather Sprandel
47 [GO] The Business & Management Collection 2024―Jul―25 Online business education: COVID-19 response Maébh Coleman
48 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Natural killer cells as COVID-19 therapy Philippa Kennedy
49 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 mRNA COVID-19 vaccine efficacy in recovered vs COVID-naive individuals E. John Wherry
50 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Oxford/AstraZeneca COVID-19 vaccine trial: adverse patient event reports Saad Shakir
51 [GO] The Business & Management Collection 2024―Jul―25 Working from home during COVID-19: an insight from Australia John Hopkins
52 [GO] The Business & Management Collection 2024―Jul―25 Planning and response to COVID-19: lessons from China and South-East Asia Annelies Wilder-Smith
53 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Planning and response to COVID-19: lessons from China and South-East Asia Annelies Wilder-Smith
54 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 COVID-19: the anti-viral immune response Danny Altmann
55 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 INFβ therapy for COVID-19: the new SNG001 drug Stephen Holgate
56 [GO] The Business & Management Collection 2024―Jul―25 COVID-19: understanding the Federal Reserve’s response and the money supply Michael McDonald
57 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Identification of a new coronavirus-specific RNA export protein complex Montse Bárcena-Martin
58 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 SARS-CoV and other emerging coronaviruses Ralph Baric
59 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Nanotechnologies in the fight against coronaviruses Sabine Szunerits
60 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 A novel AIOD-CRISPR system for diagnosis of SARS-CoV-2 Changchun Liu
61 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Development of an intranasal vaccine for SARS-CoV-2 Scot Roberts
62 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 The evolutionary origin of SARS-CoV-2 Feng Gao
63 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Approaches for elucidating genetic susceptibility to SARS-CoV-2 Kenneth Baillie
64 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Interspecies transmission of SARS-CoV-2 Dalan Bailey
65 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 The role of short linear motifs (SLiMs) in SARS-CoV-2 entry into human cells Toby Gibson
66 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 SARS-CoV-2 evolution within and between individuals Katia Koelle
67 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 SARS-CoV-2 evolution: emergence of the ‘Californian’ and ‘Indian’ variants Eric Vail
68 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 SARS-CoV-2 human monoclonal antibody therapy James Crowe
69 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 SARS-COV-2 human monoclonal antibody therapy update James Crowe
70 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 An FDA approved salivary test for SARS-CoV-2 infection Andrew Brooks
71 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Potential long-term health effects of a SARS-CoV-2 infection Danny Altmann
72 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 The cardiovascular complications of SARS-CoV-2 infection Srihari Naidu
73 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 SARS-CoV-2 monoclonal antibody testing in vivo Michael Diamond
74 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 SARS-CoV-2 mutations: phenotypes and implications for vaccine development David Montefiori
75 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 The emergence of the SARS-CoV-2 Omicron variant Emma Thomson
76 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Identifying SARS-CoV-2 proteases Christa E. Müller, Michael Gütschow
77 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 ABO blood groups and SARS-CoV-2 susceptibility Sean Stowell
78 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 SARS-CoV-2 vaccine development Stanley Plotkin
79 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 SARS-CoV-2 vaccine development: where are we now? Gary Kobinger
80 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 SARS-CoV-2 vaccine rollout campaigns Luis Graca
81 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 SARS-CoV-2 vaccine: current biological targets and considerations Adolfo Garcia-Sastre
82 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 The development of SARS-CoV-2 vaccines Peter Hotez
83 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Genetic surveillance and the emergence of SARS-CoV-2 variants Emma Thomson
84 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 SARS-CoV-2 variants: implications for immunity and vaccine development Danny Altmann
85 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 The immune system response to the SARS-CoV-2 virus Paul Klenerman
86 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 The current understanding of the biology of the SARS-CoV-2 virus Peter Palese
87 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 The paediatric response to the SARS-CoV-2 virus and what we can learn from it Sallie Permar
88 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 The immune system response to the SARS-CoV-2 virus: an update Paul Klenerman
89 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 The immune system response to the SARS-CoV-2 virus: December 2020 update Paul Klenerman
90 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 The immune system response to the SARS-CoV-2 virus: July 2020 update Paul Klenerman
91 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 The immune system response to the SARS-CoV-2 virus: March 2021 update Paul Klenerman
92 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 The role of Neuropilin-1 as a SARS-CoV-2-specific endocytosis potentiator Yohei Yamauchi
93 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Presence and function of SARS-CoV-2-specific T-cells in recovered patients and healthy volunteers Nina Le Bert
94 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 SARS-CoV-2: What we need to know and possible future therapies Stanley Perlman
95 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 The making of an influenza pandemic Jonathan Van-Tam
96 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Controlling pandemic flu John Oxford
97 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Responding to pandemic influenza Jonathan Van-Tam, Chloe Sellwood
98 [GO] The Business & Management Collection 2024―Jul―25 Plastic pandemic: how distributed ledger technology and the internet of things can create a circular economy of plastics Krishnaswamy Sankaran
99 [GO] The Biomedical & Life Sciences Collection 2024―Jul―25 Influenza virus pandemics: past and future Peter Palese
100 [GO] The Business & Management Collection 2024―Jul―25 Predictions and pandemics: why economies relapse before they recover Stephen Roach
 [1] 

100 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.007 sec